Symbols / NEXI
NEXI Chart
About
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 278.00 |
| Enterprise Value | -2.42M | Income | -20.62M | Sales | — |
| Book/sh | 0.50 | Cash/sh | 1.74 | Dividend Yield | — |
| Payout | 0.00% | Employees | 6 | IPO | — |
| P/E | — | Forward P/E | -0.00 | PEG | — |
| P/S | — | P/B | 0.00 | P/C | — |
| EV/EBITDA | 0.15 | EV/Sales | — | Quick Ratio | 0.51 |
| Current Ratio | 0.66 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -18.51 | EPS next Y | -3.75 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2023-08-10 16:00 | ROA | -72.69% |
| ROE | -232.97% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 1.39M |
| Shs Float | 1.18M | Short Float | 1.30% | Short Ratio | 2.26 |
| Short Interest | — | 52W High | 1.01 | 52W Low | 0.00 |
| Beta | 4.34 | Avg Volume | 445.00 | Volume | 100.00 |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.00 | Change | 15905748894351631254028288.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-91.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
- Nexi Stock Forecast 2026–2030 | Future Outlook - Capital.com Wed, 28 Jan 2026 08
- 10 Undervalued European Stocks | Morningstar Nordics - Morningstar Canada ue, 13 Jan 2026 08
- Assessing Nexi's (BIT:NEXI) Valuation: Is the Market Overlooking Its Potential? - Yahoo Finance Wed, 24 Sep 2025 07
- Nexi plunges close to record lows after cautious FY margin outlook - TradingView Wed, 05 Nov 2025 08
- Weighing Nexi’s Value After Five Year 70% Slide and M&A Speculation in 2025 - simplywall.st Wed, 24 Sep 2025 07
- Nexi S.p.A.: Payment Champion At A Crossroads As Investors Weigh Europe’s Digital Wallet Future - AD HOC NEWS Sun, 11 Jan 2026 08
- Nexi lowers margin outlook after slight earnings miss in Q3 - Investing.com Wed, 05 Nov 2025 08
- Italy's Nexi beats first-quarter core profit expectations - Reuters hu, 08 May 2025 07
- Italian payments firm Nexi leads race for $10 bln Nets takeover - pe-insights.com Sat, 10 May 2025 13
- Stock exchanges: Ai bubble fears abate, even Milan (+0.4%) rebounds. Nexi suffers, Fineco does well - Il Sole 24 ORE ue, 04 Nov 2025 08
- Nexi (BIT:NEXI): Taking a Fresh Look at Valuation as Investor Interest Returns Quietly - simplywall.st ue, 09 Sep 2025 07
- NexImmune Inc Is Exploding Online – But Is NEXI Stock a Hidden Gem or a Total Trap? - AD HOC NEWS Sun, 08 Feb 2026 08
- Nexi core profit jumps 7%, aims to return 600 million euros to shareholders in 2025 - Reuters Fri, 28 Feb 2025 08
- Nexi’s AI Alliance Push Raises a Bigger Question About Its Strategic Direction (BIT:NEXI) - simplywall.st Fri, 30 Jan 2026 08
- Morgan Stanley bearish on Nexi stock as FY25 growth risks weigh on valuation - Investing.com ue, 14 Jan 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -30.57M | -62.09M | -52.39M |
| TotalUnusualItems | -690.77K | 0.00 | 3.27M |
| TotalUnusualItemsExcludingGoodwill | -690.77K | 0.00 | 3.27M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -32.34M | -62.51M | -50.90M |
| ReconciledDepreciation | 1.02M | 994.79K | 870.28K |
| EBITDA | -31.26M | -62.09M | -49.13M |
| EBIT | -32.28M | -63.08M | -50.00M |
| NetInterestIncome | 698.39K | 664.37K | -852.82K |
| InterestExpense | 0.00 | 905.33K | |
| InterestIncome | 698.39K | 664.37K | 52.51K |
| NormalizedIncome | -31.65M | -62.51M | -54.17M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -32.34M | -62.51M | -50.90M |
| TotalExpenses | 32.28M | 63.08M | 53.26M |
| TotalOperatingIncomeAsReported | -32.97M | -63.08M | -53.26M |
| DilutedAverageShares | 1.05M | 962.36K | 807.45K |
| BasicAverageShares | 1.05M | 962.36K | 807.45K |
| DilutedEPS | -30.82 | -65.00 | -63.50 |
| BasicEPS | -30.82 | -65.00 | -63.50 |
| DilutedNIAvailtoComStockholders | -32.34M | -62.51M | -51.28M |
| NetIncomeCommonStockholders | -32.34M | -62.51M | -51.28M |
| PreferredStockDividends | 377.56K | ||
| NetIncome | -32.34M | -62.51M | -50.90M |
| NetIncomeIncludingNoncontrollingInterests | -32.34M | -62.51M | -50.90M |
| NetIncomeContinuousOperations | -32.34M | -62.51M | -50.90M |
| PretaxIncome | -32.34M | -62.51M | -50.90M |
| OtherIncomeExpense | -759.93K | -87.68K | 3.21M |
| OtherNonOperatingIncomeExpenses | -69.17K | -87.68K | -61.41K |
| SpecialIncomeCharges | -690.77K | 0.00 | 843.62K |
| GainOnSaleOfPPE | -690.77K | 0.00 | |
| OtherSpecialCharges | -843.62K | ||
| GainOnSaleOfSecurity | 2.42M | ||
| NetNonOperatingInterestIncomeExpense | 698.39K | 664.37K | -852.82K |
| InterestExpenseNonOperating | 0.00 | 905.33K | |
| InterestIncomeNonOperating | 698.39K | 664.37K | 52.51K |
| OperatingIncome | -32.28M | -63.08M | -53.26M |
| OperatingExpense | 32.28M | 63.08M | 53.26M |
| ResearchAndDevelopment | 19.28M | 47.15M | 37.46M |
| SellingGeneralAndAdministration | 13.00M | 15.93M | 15.80M |
| GeneralAndAdministrativeExpense | 13.00M | 15.93M | 15.80M |
| OtherGandA | 13.00M | 15.93M | 15.80M |
| TotalRevenue | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| OrdinarySharesNumber | 1.07M | 1.04M | 913.16K |
| ShareIssued | 1.07M | 1.04M | 913.16K |
| TotalDebt | 68.81K | 1.02M | 0.00 |
| TangibleBookValue | 3.51M | 32.30M | 83.76M |
| InvestedCapital | 3.51M | 32.30M | 83.76M |
| WorkingCapital | 316.73K | 27.04M | 79.06M |
| NetTangibleAssets | 3.51M | 32.30M | 83.76M |
| CapitalLeaseObligations | 68.81K | 1.02M | 0.00 |
| CommonStockEquity | 3.51M | 32.30M | 83.76M |
| TotalCapitalization | 3.51M | 32.30M | 83.76M |
| TotalEquityGrossMinorityInterest | 3.51M | 32.30M | 83.76M |
| StockholdersEquity | 3.51M | 32.30M | 83.76M |
| GainsLossesNotAffectingRetainedEarnings | 0.00 | 3.01K | |
| OtherEquityAdjustments | 3.01K | ||
| RetainedEarnings | -222.59M | -190.25M | -127.74M |
| AdditionalPaidInCapital | 226.10M | 222.55M | 211.50M |
| CapitalStock | 2.65K | 2.61K | 2.28K |
| CommonStock | 2.65K | 2.61K | 2.28K |
| TotalLiabilitiesNetMinorityInterest | 5.08M | 10.76M | 7.27M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 425.77K | 55.58K |
| NonCurrentDeferredLiabilities | 0.00 | 55.58K | |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 425.77K | 0.00 |
| LongTermCapitalLeaseObligation | 0.00 | 425.77K | 0.00 |
| CurrentLiabilities | 5.08M | 10.33M | 7.22M |
| CurrentDebtAndCapitalLeaseObligation | 68.81K | 599.05K | |
| CurrentCapitalLeaseObligation | 68.81K | 599.05K | 0.00 |
| PayablesAndAccruedExpenses | 5.02M | 9.73M | 7.22M |
| CurrentAccruedExpenses | 3.68M | 7.36M | 6.17M |
| Payables | 1.34M | 2.38M | 1.05M |
| AccountsPayable | 1.34M | 2.38M | 1.05M |
| TotalAssets | 8.59M | 43.06M | 91.03M |
| TotalNonCurrentAssets | 3.19M | 5.69M | 4.75M |
| OtherNonCurrentAssets | 1.79M | 264.97K | 324.10K |
| NetPPE | 1.40M | 5.43M | 4.43M |
| AccumulatedDepreciation | -1.55M | -3.23M | -2.28M |
| GrossPPE | 2.95M | 8.66M | 6.71M |
| Leases | 36.46K | 319.82K | 230.15K |
| OtherProperties | 2.71M | 7.77M | 5.94M |
| MachineryFurnitureEquipment | 202.96K | 564.85K | 534.70K |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 5.40M | 37.37M | 86.28M |
| OtherCurrentAssets | 215.25K | 401.92K | 99.19K |
| RestrictedCash | 20.00K | 55.00K | 67.50K |
| PrepaidAssets | 519.22K | 2.20M | 4.30M |
| Receivables | 0.00 | 74.47K | 0.00 |
| AccruedInterestReceivable | 0.00 | 74.47K | 0.00 |
| CashCashEquivalentsAndShortTermInvestments | 4.65M | 34.64M | 81.82M |
| OtherShortTermInvestments | 1.44M | 0.00 | 51.49M |
| CashAndCashEquivalents | 3.20M | 34.64M | 30.33M |
| CashEquivalents | 27.62M | ||
| CashFinancial | 2.70M |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| FreeCashFlow | -31.48M | -52.45M | -48.14M |
| RepaymentOfDebt | 0.00 | -12.26K | |
| IssuanceOfDebt | 0.00 | 9.03M | |
| IssuanceOfCapitalStock | 0.00 | 5.15M | 114.72M |
| CapitalExpenditure | -48.72K | -1.26M | -2.35M |
| InterestPaidSupplementalData | 0.00 | 457.00 | |
| EndCashPosition | 3.22M | 34.70M | 30.39M |
| BeginningCashPosition | 34.70M | 30.39M | 5.10M |
| ChangesInCash | -31.47M | 4.30M | 25.30M |
| FinancingCashFlow | 0.00 | 5.18M | 124.89M |
| CashFlowFromContinuingFinancingActivities | 0.00 | 5.18M | 124.89M |
| NetOtherFinancingCharges | -19.14K | ||
| ProceedsFromStockOptionExercised | 0.00 | 33.26K | 1.17M |
| NetCommonStockIssuance | 0.00 | 5.15M | 114.72M |
| CommonStockIssuance | 0.00 | 5.15M | 114.72M |
| NetIssuancePaymentsOfDebt | 0.00 | 9.02M | |
| NetLongTermDebtIssuance | 0.00 | 9.02M | |
| LongTermDebtPayments | 0.00 | -12.26K | |
| LongTermDebtIssuance | 0.00 | 9.03M | |
| InvestingCashFlow | -44.49K | 50.32M | -53.81M |
| CashFlowFromContinuingInvestingActivities | -44.49K | 50.32M | -53.81M |
| NetInvestmentPurchaseAndSale | 0.00 | 51.49M | -51.46M |
| SaleOfInvestment | 0.00 | 73.00M | 39.00M |
| PurchaseOfInvestment | 0.00 | -21.51M | -90.46M |
| NetPPEPurchaseAndSale | -44.49K | -1.17M | -2.35M |
| SaleOfPPE | 4.23K | 80.80K | 0.00 |
| PurchaseOfPPE | -48.72K | -1.26M | -2.35M |
| OperatingCashFlow | -31.43M | -51.19M | -45.79M |
| CashFlowFromContinuingOperatingActivities | -31.43M | -51.19M | -45.79M |
| ChangeInWorkingCapital | -4.88M | 3.93M | 654.57K |
| ChangeInOtherCurrentLiabilities | -573.10K | -498.35K | 0.00 |
| ChangeInOtherCurrentAssets | -1.53M | 59.13K | -300.73K |
| ChangeInPayablesAndAccruedExpense | -4.72M | 2.65M | 3.01M |
| ChangeInAccruedExpense | -3.68M | 1.26M | 4.01M |
| ChangeInPayable | -1.04M | 1.39M | -1.00M |
| ChangeInAccountPayable | -1.04M | 1.39M | -1.00M |
| ChangeInPrepaidAssets | 1.95M | 1.72M | -2.05M |
| OtherNonCashItems | 537.41K | 500.55K | 903.92K |
| StockBasedCompensation | 3.55M | 5.87M | 5.98M |
| AmortizationOfSecurities | 0.00 | -1.13K | -32.06K |
| DepreciationAmortizationDepletion | 1.02M | 994.79K | 870.28K |
| DepreciationAndAmortization | 1.02M | 994.79K | 870.28K |
| OperatingGainsLosses | 676.28K | 21.26K | -3.26M |
| GainLossOnInvestmentSecurities | -2.42M | ||
| NetIncomeFromContinuingOperations | -32.34M | -62.51M | -50.90M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NEXI
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|